NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Gray RN, McCrory DC, Eberlein K, et al. Parenteral Drug Treatments for Acute Migraine Headache. Rockville (MD): Agency for Health Care Policy and Research (US); 1999 Feb. (Technical Reviews, No. 2.5.)

Cover of Parenteral Drug Treatments for Acute Migraine Headache

Parenteral Drug Treatments for Acute Migraine Headache.

Show details

References

  1. Ad Hoc Committee on the Classification of Headache, National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA. 1962;179:717–8.
  2. Belgrade MJ, Ling LJ, Schleevogt MB, Ettinger MG, Ruiz E. Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache. Neurology. 1989;39(4):590–2. [PubMed: 2648190]
  3. Bell R, Montoya D, Shuaib A, Lee MA. A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med. 1990;19(10):1079–82. [PubMed: 2221511]
  4. Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache. 1986;26(4):168–71. [PubMed: 3519528]
  5. Cameron JD, Lane PL, Speechley M. Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache. Acad Emerg Med. 1995;2(7):597–602. [PubMed: 8521205]
  6. Celentano DD, Stewart WF, Lipton RB, Reed ML. Medication use and disability among migraineurs: a national probability sample survey. Headache. 1992;32(5):223–8. [PubMed: 1628958]
  7. Chappell AS, Bay JM, Botzum GD, Cohen ML. Zatosetron, a 5-HT3 receptor antagonist in a multicenter trial for acute migraine. Neuropharmacology. 1994;33(3–4):509–13. [PubMed: 7984290]
  8. Clouse JC, Osterhaus JT. Healthcare resource use and costs associated with migraine in a managed healthcare setting. Ann Pharmacother. 1994;28(5):659–64. [PubMed: 8069007]
  9. Cochrane Controlled Trials Register (CCTR) [computer program] The Cochrane Library, CD-ROM for Windows (IBM-PC) version. London: BMJ Publishing Group; 1997.
  10. Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: L Erlbaum Associates; 1988.
  11. Coppola M, Yealy DM, Leibold RA. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med. 1995;26(5):541–6. [PubMed: 7486359]
  12. Davis CP, Torre PR, Williams C, Gray C, Barrett K, Krucke G, Peake D, Bass B Jr. Ketorolac versus meperidine-plus-promethazine treatment of migraine headache: evaluations by patients. Am J Emerg Med. 1995;13(2):146–50. [PubMed: 7893296]
  13. Del Bene E, Poggioni M, Garagiola U, Maresca V. Intramuscular treatment of migraine attacks using diclofenac sodium: a crossover clinical trial. J Int Med Res. 1987;15(1):44–8. [PubMed: 3545942]
  14. Diamond S, Freitag FG. Analgesic efficacy and safety of TNB in the acute treatment of migraine. Clin Pharmacol Ther. 1990;47(2):135.
  15. Diamond S, Freitag FG, Diamond ML, Urban G. Transnasal butorphanol in the treatment of migraine headache pain. Headache Quarterly. 1992;3(2):164–171.
  16. Diamond S, Freitag FG, Gallagher RM, Chu G, Mosnaim AD. The analgesic efficacy of transnasal butorphanol (TNB) in the acute treatment of migraine. Cephalalgia. 1989;9(Suppl 10):357.
  17. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ. 1994;309(6964):1286–91. [PMC free article: PMC2541778] [PubMed: 7718048]
  18. Duarte C, Dunaway F, Turner L, Aldag J, Frederick R. Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: a randomized, prospective, double-blind trial. Ann Emerg Med. 1992;21(9):1116–21. [PubMed: 1514724]
  19. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci. 1993;20(2):131–7. [PubMed: 8334575]
  20. Elenbaas RM, Iacono CD, Koellner KJ, Pribble JP, Gratton M, Racz G, Evens RP. Dose effectiveness and safety of butorphanol in acute migraine headache. Pharmacotherapy. 1991;11(1):56–63. [PubMed: 2020612]
  21. Ellis GL, Delaney J, DeHart DA, Owens A. The efficacy of metoclopramide in the treatment of migraine headache. Ann Emerg Med. 1993;22(2):191–5. [PubMed: 8427430]
  22. Fleiss JL. Statistical methods for rates and proportions. 2. New York: John Wiley & Sons, Inc; 1981.
  23. Freitag FG. The acute treatment of migraine with transnasal butorphanol (TNB) Headache Quarterly. 1993;4(Suppl 3):22–28.
  24. Harden RN, Gracely RH, Carter T, Warner G. The placebo effect in acute headache management: ketorolac, meperidine, and saline in the emergency department. Headache. 1996;36(6):352–6. [PubMed: 8707552]
  25. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(Suppl 7):1–96. [PubMed: 3048700]
  26. International Headache Society Committee on Clinical Trials in Migraine. Guidelines for controlled trials of drugs in migraine. Cephalalgia. (1) 1991;11(1):1–12. [PubMed: 2036663]
  27. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials. 1996;17(1):1–12. [PubMed: 8721797]
  28. Jones EB, Gonzalez ER, Boggs JG, Grillo JA, Elswick RK Jr. Safety and efficacy of rectal prochlorperazine for the treatment of migraine in the emergency department. Ann Emerg Med. 1994;24(2):237–41. [PubMed: 8037389]
  29. Jones J, Pack S, Chun E. Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache. Am J Emerg Med. 1996;14(3):262–4. [PubMed: 8639197]
  30. Jones J, Sklar D, Dougherty J, White W. Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. JAMA. 1989;261(8):1174–6. [PubMed: 2915441]
  31. Karachalios GN, Fotiadou A, Chrisikos N, Karabetsos A, Kehagioglou K. Treatment of acute migraine attack with diclofenac sodium: a double-blind study. Headache. 1992;32(2):98–100. [PubMed: 1551795]
  32. Keele KD. The pain chart. Lancet. 1948;2:6–8. [PubMed: 18871952]
  33. Klapper J, Stanton J. The emergency treatment of acute migraine headache; a comparison of intravenous dihydroergotamine, dexamethasone, and placebo. Cephalalgia. 1991;11(Suppl 11):159–160.
  34. Klapper JA, Stanton J. Current emergency treatment of severe migraine headaches. Headache. 1993;33(10):560–2. [PubMed: 8294195]
  35. Kozubski W. Metamizole and hydrocortisone for the interruption of a migraine attack--preliminary study. Headache Quarterly. 1992;3(3):326–8.
  36. Lane PL, McLellan BA, Baggoley CJ. Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Ann Emerg Med. 1989;18(4):360–5. [PubMed: 2705667]
  37. Larkin GL, Prescott JE. A randomized, double-blind, comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine. Ann Emerg Med. 1992;21(8):919–24. [PubMed: 1497157]
  38. Linet MS, Stewart WF, Celentano DD, Ziegler D, Sprecher M. An epidemiologic study of headache among adolescents and young adults. JAMA. 1989;261(15):2211–6. [PubMed: 2926969]
  39. Littman GS, Walker BR, Schneider BE. Reassessment of verbal and visual analog ratings in analgesic studies. Clin Pharmacol Ther. 1985;38(1):16–23. [PubMed: 3891192]
  40. Maizels M, Scott B, Cohen W, Chen W. Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial. JAMA. 1996;276(4):319–21. [PubMed: 8656545]
  41. McEwen JI, O’Connor HM, Dinsdale HB. Treatment of migraine with intramuscular chlorpromazine. Ann Emerg Med. 1987a;16(7):758–63. [PubMed: 3592329]
  42. McEwen J, O’Connor H, Dinsdale H. Treating migraine with chlorpromazine. Nurses Drug Alert. 1987b;11(11):87.
  43. Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Controlled Clin Trials. 1995;16(1):62–73. [PubMed: 7743790]
  44. Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labour costs of migraine headache in the US. Pharmacoeconomics. 1992;2(1):67–76. [PubMed: 10146980]
  45. Reutens DC, Fatovich DM, Stewart-Wynne EG, Prentice DA. Is intravenous lidocaine clinically effective in acute migraine? Cephalalgia. 1991;11( 6):245–7. [PubMed: 1790567]
  46. Rowat BM, Merrill CF, Davis A, South V. A double-blind comparison of granisetron and placebo for the treatment of acute migraine in the emergency department. Cephalalgia. 1991;11(5):207–13. [PubMed: 1663423]
  47. Sacks W. The use of an isopyrine-phenylbutazone compound in migraine. S Afr Med J. 1980;58(11):444–6. [PubMed: 6996149]
  48. Scherl ER, Wilson JF. Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. Headache. 1995;35(5):256–9. [PubMed: 7775186]
  49. Scott J, Huskisson EC. Graphic representation of pain. Pain. 1976;2(2):175–84. [PubMed: 1026900]
  50. Shrestha M, Singh R, Moreden J, Hayes JE. Ketorolac vs chlorpromazine in the treatment of acute migraine without aura. A prospective, randomized, double-blind trial. Arch Intern Med. 1996;156(15):1725–8. [PubMed: 8694672]
  51. Stewart WF, Shechter A, Lipton RB. Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration. Neurology. 1994;44(6 Suppl 4):S24–39. [PubMed: 8008223]
  52. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence. A review of population-based studies. Neurology. 1994;44(6 Suppl 4):S17–23. [PubMed: 8008222]
  53. Stiell IG, Dufour DG, Moher D, Yen M, Beilby WJ, Smith NA. Methotrimeprazine versus meperidine and dimenhydrinate in the treatment of severe migraine: a randomized, controlled trial. Ann Emerg Med. 1991;20(11):1201–5. [PubMed: 1952306]
  54. Tek DS, McClellan DS, Olshaker JS, Allen CL, Arthur DC. A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann Emerg Med. 1990;19(10):1083–7. [PubMed: 2221512]
  55. Tek D, Mellon M. The effectiveness of nalbuphine and hydroxyzine for the emergency treatment of severe headache. Ann Emerg Med. 1987;16(3):308–13. [PubMed: 3544982]
  56. Tfelt-Hansen P, Jensen K, Vendsborg P, Lauritzen M, Olesen J. Chlormezanone in the treatment of migraine attacks: a double blind comparison with diazepam and placebo. Cephalalgia. 1982;2(4):205–10. [PubMed: 6760981]
  57. Tfelt-Hansen P, Olesen J, Aebelholt-Krabbe A, Melgaard B, Veilis B. A double blind study of metoclopramide in the treatment of migraine attacks. J Neurol Neurosurg Psychiatry. 1980;43(4):369–71. [PMC free article: PMC490544] [PubMed: 7373338]
  58. Thomas SH, Stone CK, Ray VG, Whitley TW. Intravenous versus rectal prochlorperazine in the treatment of benign vascular or tension headache: a randomized, prospective, double-blind trial. Ann Emerg Med. 1994;24(5):923–7. [PubMed: 7978566]
  59. Wallenstein SL, Heidrich G 3d, Kaiko R, Houde RW. Clinical evaluation of mild analgesics: the measurement of clinical pain. Br J Clin Pharmacol. 1980 Oct;10(Suppl 2):319S–327S. [PMC free article: PMC1430185] [PubMed: 7437271]
  60. Winner P, Dalessio D, Mathew N, Sadowsky C, Turkewitz LJ, Sheftell F, Silberstein SD, Solomon S. Concomitant administration of antiemetics is not necessary with intramuscular dihydroergotamine. Am J Emerg Med. 1994;12(2):138–41. [PubMed: 8161382]
  61. Winner P, Ricalde O, Leforce B, Saper J, Margul B. A double-blind study of subcutaneous dihydroergotamine vs. subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol. 1996;53(2):180–184. [PubMed: 8639069]

Views

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...